This study aimed to evaluate improvements in the rate of detection of prostate cancer using an extensive protocol involving peripheral zone biopsies.
Method
Seventy patients (mean age: 66.5 AE 69 y) were submitted to TRUS-guided prostate biopsies for increased prostate speci®c antigen (PSA b 4 ngaml). Mean PSA was 10.5 AE 10.9 ngaml. In this new protocol, ®ve biopsies were performed in each lobe. Beside the three standard biopsies (taken at 45 angle), two additional biopsies (one at the base and one at the mid-lobe) were taken at a 30 angle sampling the peripheral zone. An additional peripheral biopsy was taken at the apex if there was a prostate volume b 50 cm 3 . This biopsy protocol took place on an outpatient basis.
Results
No additional morbidity was noted. Thirty patients (42.9%) were positive for prostate cancer with a mean PSA of 12.8 AE 8.8 ngaml. Five of these patients had positive peripheral biopsies only and would have been missed by the standard`Hodge' protocol. The rate of prostate cancer detection changed therefore from 35.7% (25a70) to 42.9%, with an overall percentage improvement in positive diagnosis of 7.2%
Conclusion
These preliminary results show that peripheral biopsy sampling of the prostate allows a 7.2% additional rate of cancer detection. The extensive protocol described above may be achieved on an outpatient basis and is therefore applicable to a screening population with no further morbidity.
